CU Medical Systems, Inc.
Financials
Valuation Metrics
CU Medical Systems, Inc.'s Market Cap is ₩232B. At end of 2025 it was ₩333B. Ranked #2180 of 2,405 in KR market (top 91%), #1422 of 1,627 on KOSDAQ (top 87%), #88 of 94 in Health Care Equipment & Services (top 94%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 23.23B KRW | KR#2,180/2,405 Sec#88/94 |
| Revenue | 63.43B KRW | KR#1,661/2,405 Sec#49/94 |
| Net Income | 9.13B KRW | KR#1,001/2,405 Sec#27/94 |
| Total Assets | 139.92B KRW | KR#1,557/2,405 Sec#46/94 |
| Net Assets | 79.86B KRW | KR#1,589/2,405 Sec#46/94 |
| Employees | 120 | KR#1,502/2,405 Sec#52/94 |
| Value | ||
| P/E | 2.54x | KR#133/2,405 Sec#2/94 |
| P/B | 0.29x | KR#369/2,405 Sec#4/94 |
| P/S | 0.37x | KR#762/2,405 Sec#5/94 |
| EV/EBITDA | 2.66x | KR#91/2,405 Sec#2/94 |
| FCF Yield | 39.37% | KR#145/2,405 Sec#1/94 |
| Profitability | ||
| ROE | 11.43% | KR#513/2,405 Sec#22/94 |
| ROA | 6.53% | KR#569/2,405 Sec#30/94 |
| Op. Margin | 23.42% | KR#114/2,405 Sec#8/94 |
| Revenue Growth | 55.49% | KR#175/2,405 Sec#11/94 |
| Financial Health | ||
| Debt Ratio | 75.20% | KR#1,275/2,405 Sec#70/94 |
| Total Debt | 47.21B KRW | KR#1,027/2,405 Sec#25/94 |
| FCF | 9.15B KRW | KR#732/2,405 Sec#18/94 |
| Cash | 30.92B KRW | KR#995/2,405 Sec#25/94 |
| Current Ratio | 1.17x | KR#1,519/2,405 Sec#74/94 |
| Net Debt/EBITDA | 1.10x | KR#744/2,405 Sec#32/94 |
| Performance | ||
| 1Y Return | -35.49% | KR#1,553/2,405 Sec#51/94 |
| 1M Return | -16.33% | KR#1,659/2,405 Sec#69/94 |
| From 52W High | -42.11% | KR#832/2,405 Sec#33/94 |
| 1Y MDD | -47.05% | KR#823/2,405 Sec#29/94 |
| Trading | ||
| Volume | 13,521 shares | KR#1,702/2,405 Sec#67/94 |
| Trading Value | 25.8M KRW | KR#2,007/2,405 Sec#80/94 |
| Foreign Own. | 0.00% | KR—/2,405 Sec—/94 |
| Per Share | ||
| EPS | 753 KRW | KR#837/2,405 Sec#19/94 |
| BPS | 6,587 KRW | KR#1,300/2,405 Sec#30/94 |
Company Info
CU Medical, established in 2001 and headquartered in Wonju-si, Gangwon-do, listed on KOSDAQ in 2011. The company specializes in developing, manufacturing, and selling medical devices, notably being the first in Asia to develop and market defibrillators. It offers a comprehensive product range, from general-use to hospital-specific devices, and is launching new Automated External Defibrillator (AED) products with world-first IP66 and IP68 ratings. With local subsidiaries in Germany and Japan, CU Medical implements tailored sales strategies for global markets.